Insmed Incorporated 8-K Report: Key Updates on January 10, 2025

Based on the provided section of the financial report, here are the key pieces of information extracted:
- Entity Information:
- Company Name: Insmed Incorporated
- CIK: 0001104506
- SEC File Number: 000-30739
- EIN: 54-1972729
- Address: 700 US Highway 202/206, Bridgewater, NJ 08807
- Phone Number: 908-977-9900
- Filing Details:
- Filing Type: 8-K (Current Report)
- Filing Date: January 10, 2025
- Stock Information:
- Common Stock: Par value of $0.01 per share
- Stock Exchange: NASDAQ
- Reporting Period:
- Start Date: January 10, 2025
- End Date: January 10, 2025
Insights:
- The filing is an 8-K, which is used to disclose significant events that shareholders should know about. This typically includes mergers, acquisitions, executive changes, or other major corporate events.
- The report is specifically dated for a single day (January 10, 2025), indicating that the event being reported may have occurred on that date or is relevant to that specific date.
- The company is publicly traded on NASDAQ, which can be relevant for investors tracking its performance.
Overall, this filing marks an important event for Insmed Incorporated that may affect its stock performance or investor sentiment. Further details in the complete report would provide more context about the specific event being reported.